Read Our

Equisights Research (“Equisights”) is a distinguished independent sell-side research firm that excels in delivering in-depth, objective analysis and strategic insights. Our research efforts are primarily centered on the U.S. markets, with a strong sectoral emphasis on Technology, Media, and Telecommunications (TMT), healthcare, consumer cyclicals & non-cyclicals, industrials, energy, and select financials. Equisights serves to several notable buy-side funds, RIAs, family offices, and over 1,000 institutional relationships, who take positions across our coverage universe and manage portfolios ranging from $100 million to $1 billion in assets.

Our comprehensive research framework involves an in-depth analysis of each company’s growth potential, financial health, management quality, industry position, risk factors, and valuation. Our recommendations and ratings process is based on gathering and interpreting data, drawing conclusions, and evaluating these factors to determine final ratings based on intrinsic value, expected growth, and risks. Equisights maintains its independence by not participating in public offerings, advising on mergers and acquisitions, brokering trades, making markets in stocks, or managing money.

RESEARCH FEED : OUR PERSPECTIVE

19 Nov, 2024

AstraZeneca Inc (AZN): Dato-DXd Setbacks & Shifts—What’s the Impact on Lung Cancer Pipeline, Growth Outlook & Key Strategic Levers?

AstraZeneca’s Q3 2024 results highlight strong operational execution, with 21% revenue growth and upgraded full-year guidance for high-teen percentage increases in revenue and EPS. Oncology (+22% YTD) remained a standout, driven by Enhertu (+55%), Tagrisso (+17%), and Calquence (+25%), alongside promising data from AMPLIFY, SERENA-6, and DESTINY-Breast09. Biopharma’s respiratory portfolio show... Read More
19 Nov, 2024

Spotify Inc (SPOT): Profitability Ramp Gains Astounding Pace—What Are the 5 Key Drivers Behind Its Future Growth & Fair Value Upside?

Spotify’s Q3 2024 results showcased strong operational performance, with record gross margin of 31.1% (+90 bps above guidance), €711 million in free cash flow, and €454 million in operating income. Premium subscribers grew to 252 million (+6 million net additions), and MAUs reached 640 million, both exceeding forecasts and reinforcing user engagement. However, revenue of $4.23 billion missed... Read More
19 Nov, 2024

Home Depot Inc.(HD): Pro Investments & Hurricane Boost Amid DITY Slowdown—What’s the Real Growth Impact, Outlook & Its 5 Key Catalysts?

Home Depot’s Q3 2024 results demonstrated strong operational execution, with revenue of $40.22 billion (+6.6% YoY) exceeding estimates by $898 million, driven by hurricane-related demand and favorable weather. Adjusted EPS of $3.78 surpassed expectations by $0.12, reflecting disciplined cost controls and productivity gains, despite a 1.3% decline in comparable sales. Pro sales outperformed DIY, ... Read More
19 Nov, 2024

Becton, Dickinson & Co (BDX): Strong Finish, But Weak China and Still Soft Biopharma Demand Headwinds Loom—What’s the Impact, Outlook & Key Catalysts Behind Our Bullish View?

Becton Dickinson (BDX) delivered a robust FY2024 performance, with Q4 revenue of $5.44 billion (+7.4% YoY) and adjusted EPS of $3.81, beating expectations. Full-year organic revenue grew 5%, driven by strong execution across key franchises such as PureWick, pharmacy robotics, and biologic drug delivery, which crossed $1 billion in annual revenue. Adjusted operating margins expanded to 24.2%, refle... Read More
19 Nov, 2024

Kenvue (KVUE): Weak Pricing Power and Slow SHB Recovery—What does Future oulook hinge upon ? Can the Company Overcome Regional Challenges?

Kenvue's Q3 2024 results reflect resilience amid ongoing transformation initiatives, with revenue of $3.90 billion missing estimates by $19.32 million and organic growth of 0.9% at the low end of guidance. Adjusted EPS of $0.28 surpassed expectations by $0.01, driven by cost efficiencies, while GAAP EPS of $0.20 missed by $0.03. Segment performance was mixed: Self-Care posted modest organic growth... Read More
19 Nov, 2024

Universal Display Corporation (OLED): Phosphorescent Blue Innovation as the Catalyst for OLED Market Leadership –what’s the impact of Commercialization, Outlook & its 5 Key Catalysts ?

Universal Display Corporation reported Q3 2024 revenues of $161.63 million, up 15% YoY, driven by a robust 63% growth in royalty and license fees. However, material sales declined by 10% YoY, contributing to a $3.41 million revenue miss. Operating margins improved to 41% (vs. 34% in Q3 2023), reflecting strong cost discipline and an optimized revenue mix. Adjusted and GAAP EPS of $1.40 beat expect... Read More
19 Nov, 2024

Interpublic Group (IPG): Scaling Principal Media Buying to Drive Competitive Edge – Can New Strategic Initiatives Revive Topline Growth?

Interpublic Group's (IPG) Q3 2024 results reflect operational resilience amid revenue challenges, with Adjusted EPS of $0.70 meeting expectations and revenue of $2.24 billion falling short by $66.11 million. Organic revenue growth was flat YoY, impacted by sectoral headwinds in technology, telecom, and automotive. While U.S. revenue remained flat, Latin America grew (+9.8%), and Europe saw modest ... Read More
19 Nov, 2024

Roku Inc: Platform Monetization Takes Center Stage – Will It Be Hard to Sustain This Level of Growth?

Roku’s Q3 2024 results showcased strong execution, with total revenue surpassing $1 billion for the first time, up 16% YoY. Platform revenue grew 15% YoY, driven by higher engagement and strategic ad innovations. Adjusted EPS of $0.07 beat expectations by $0.41, underscoring cost efficiencies. User engagement reached new highs, with streaming hours rising 20% YoY and ARPU stabilizing at $41.10, ... Read More
19 Nov, 2024

EPAM Systems Inc : Can Geographic Expansion Match Eastern Europe’s Success Amid Wage Pressures and Sector Headwinds- What’s the Impact, Outlook & Its 6 Key Catalysts?

EPAM Systems delivered stronger-than-expected Q3 2024 results, with revenue of $1.168 billion (+1.3% YoY) and adjusted EPS of $3.12, driven by stabilization across geographies and verticals. Financial services grew +3.3% YoY, life sciences & healthcare expanded +14.6% YoY, and software/hi-tech rose +2.1% YoY, reflecting improving client demand. Geographic diversification gained traction, with ... Read More
18 Nov, 2024

Akamai Technologies Inc. (AKAM): Compute and Security Powering a New Growth Era—What’s the Impact, Outlook & Its 5 Key Catalysts ?

Akamai achieved a milestone in Q3 2024, surpassing $1 billion in revenue, driven by its pivot to security and cloud compute solutions. Compute and Security now account for 68% of revenue, growing 17% YoY in constant currency. Compute revenue surged 28% YoY to $167M, supported by demand in retail, SaaS, and gaming, while Security revenue rose 14% YoY to $519M, fueled by Zero Trust and API Security ... Read More
Earnings
Market Pulse
Deals
Scroll to Top